References
- Ross MG, Nijland MJ. 1-Deamino-[8-D-arginine] vasopressin-induced maternal plasma hypoosmolality increases ovine amniotic fluid volume. Am J Obstet Gynecol [Internet]. 1996 [cited 2023 Sep 1];174(4):1118–25. Available from:
https://pubmed.ncbi.nlm.nih.gov/8623838/ - Davison JM, Shiells EA, Philips PR, Undheimer MD, Davison JM, Shiells EA, et al. Serial Evaluation of Vasopressin Release and Thirst in Human Pregnancy Role of Human Chorionic Gonadotrophin in the Osmoregulatory Changes of Gestation. J Clin Invest. 1988;81.
- Brunton PJ, Arunachalam S, Russell JA. Control of Neurohypophysial Hormone Secretion, Blood Osmolality and Volume in Pregnancy. J Physiol Pharmacol [Internet]. 2008;59(8):27–45. Available from:
www.jpp.krakow.pl - Cheung KL, Lafayette RA. Renal Physiology of Pregnancy. Adv Chronic Kidney Dis. 2013;20:209–14.
- Xodo S, Cecchini F, Celante L, Novak A, Rossetti E, Baccarini G, et al. Preeclampsia and low sodium: A retrospective cohort analysis and literature review. Pregnancy Hypertens. 2021 Mar 1;23:169–73.
- Singhi SC, Chookang E. Maternal fluid overload during labour; transplacental hyponatraemia and risk of transient neonatal tachypnoea in term infants. Arch Dis Child. 1984;59.
- Nijland MJ, Ross MG, Kullama LK, Bradley K, Gore Ervin M, Ri MJ, et al. DDAVP-induced maternal hyposmolality increases ovine fetal urine flow. Am J Physiol [Internet]. 1995;268(2): 358–68. Available from:
www.physiology.org/journal/ajpregu - Ross MG, Cedars L, Nijland M, Ogundipe A, Angeles L. Treatment of oligohydramnios with maternal 1-deamino-[8-D-arginine] vasopressin-induced plasma hypoosmolality. Am J Obstet Gynecol. 1996;174(5):1608–13.
- English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control [Internet]. 2015 Mar 3 [cited 2024 May 7];8:7–12. Available from:
https://www.tandfonline.com/action/journalInformation?journalCode=dibp20 - Razavi AS, Chasen ST, Gyawali R, Kalish RB. Hyponatremia associated with preeclampsia. J Perinat Med. 2017 May 1;45(4):467–70.
- Hinkson L, Armbrust R, Möller A, Henrich W. Case report of severe maternal hyponatremia complicating preeclampsia. J Matern Fetal Neonatal Med. 2018 Jul 18;31(14):1948–9.
- Ross MG, Nijland MJM, Kullama LK, Woods JA, Goodlin RC, Cefalo RC, et al. 1-Deamino-[8-D-arginine] vasopressin-induced maternal plasma hypoosmolality increases ovine amniotic fluid volume. Am J Obstet Gynecol [Internet]. 1996 [cited 2022 Dec 17];174(4):1118–27. Available from:
https://pubmed.ncbi.nlm.nih.gov/8623838/ - Roberts TJ, Nijland MJM, Curran M, Ross MG. Maternal 1-de amino-8-D-arginine-vasopressin-induced sequential decreases in plasma sodium concentration: ovine fetal renal responses. Am J Obstet Gynecol [Internet]. 1999 [cited 2022 Dec 17];180 (1 Pt 1):82–90. Available from:
https://pubmed.ncbi.nlm.nih.gov/9914583/ - Castaman G, James PD. Pregnancy and delivery in women with von Willebrand disease. Eur J Haematol [Internet]. 2019 Aug 1 [cited 2022 Dec 15];103(2):73–9. Available from:
https://onlinelibrary.wiley.com/doi/full/10.1111/ejh.13250 - Karanth L, Barua A, Kanagasabai S, Sreekumaran Nair N. Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders. Cochrane Database Syst Rev [Internet]. 2019 Feb 13 [cited 2022 Dec 15];2019(2). Available from: /pmc/articles/PMC6373982/
- Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Blood [Internet]. 2005 Apr 15 [cited 2022 Dec 15];105(8):3382. Available from:
https://pubmed.ncbi.nlm.nih.gov/15802549/ - Ray JG, Boskovic R, Knie B, Hard M, Portnoi G, Koren G. In vitro analysis of human transplacental transport of desmopressin. Clin Biochem [Internet]. 2004 [cited 2022 Dec 15];37(1):10–3. Available from:
https://pubmed.ncbi.nlm.nih.gov/14675556/ - Belzile M, Pouliot A, Cumyn A, Côté AM. Renal physiology and fluid and electrolyte disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019 May;57:1–14.
- Federici AB. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007). Hemophilia. 2008;14(1):5–14.
- Teke HÜ, Başak M, Teke D, Kanbay M. DDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency. Turk J Hematol [Internet]. 2013 [cited 2024 May 7];30(2):214. Available from: /pmc/articles/PMC3878470/